PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung

por Janzic, Urska, Kern, Izidor, Janzic, Andrej, Cavka, Luka, Cufer, Tanja
Publicado 2017

Various Clinical Presentations of Uveitis Associated with Durvalumab Treatment

por Vrabic, Nika, Fakin, Ana, Mekjavic, Polona Jaki, Janzic, Urska, Vrankar, Martina, Valentincic, Natasa Vidovic
Publicado 2022

Real-world Outcomes, Treatment Patterns and T790M Testing Rates in Non-small Cell Lung Cancer Patients Treated with First-line First- or Second-generation Epidermal Growth Factor R...

por Turnsek, Nina, Devjak, Rok, Edelbaher, Natalija, Osrajnik, Ilonka, Unk, Mojca, Vidovic, Dusanka, Jeric, Tina, Janzic, Urska
Publicado 2022

Real-World Testing Practices, Treatment Patterns and Clinical Outcomes in Patients from Central Eastern Europe with EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Retrospectiv...

por Janžič, Urška, Turnšek, Nina, Dediu, Mircea, Donev, Ivan Shterev, Lupu, Roxana, Teodorescu, Gabriela, Ciuleanu, Tudor E., Pluzanski, Adam
Publicado 2022

A Three-Dose mRNA COVID-19 Vaccine Regime Produces Both Suitable Immunogenicity and Satisfactory Efficacy in Patients with Solid Cancers

por Janzic, Urska, Bidovec-Stojkovic, Urska, Korosec, Peter, Mohorcic, Katja, Mrak, Loredana, Caks, Marina, Ravnik, Maja, Skof, Erik, Rijavec, Matija
Publicado 2023

Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations

por Janzic, Urska, Shalata, Walid, Szymczak, Katarzyna, Dziadziuszko, Rafał, Jakopovic, Marko, Mountzios, Giannis, Płużański, Adam, Araujo, Antonio, Charpidou, Andriani, Agbarya, Abed
Publicado 2023

Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT)

por Addeo, Alfredo, Hochmair, Maximilian, Janzic, Urska, Dudnik, Elizabeth, Charpidou, Andriani, Płużański, Adam, Ciuleanu, Tudor, Donev, Ivan Shterev, Elbaz, Judith, Aarøe, Jørgen, Ott, René, Peled, Nir
Publicado 2021

Solid cancer patients achieve adequate immunogenicity and low rate of severe adverse events after SARS-CoV-2 vaccination

por Janzic, Urska, Bidovec-Stojkovic, Urska, Mohorcic, Katja, Mrak, Loredana, Dovnik, Nina Fokter, Ivanovic, Marija, Ravnik, Maja, Caks, Marina, Skof, Erik, Debeljak, Jerneja, Korosec, Peter, Rijavec, Matija
Publicado 2022

Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis

por Ljubicic, Lidija, Janzic, Urska, Unk, Mojca, Terglav, Ana Sophie, Mohorcic, Katja, Seiwerth, Fran, Bitar, Lela, Badovinac, Sonja, Plestina, Sanja, Korsic, Marta, Kukulj, Suzana, Samarzija, Miroslav, Jakopovic, Marko
Publicado 2023

Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments

por Agbarya, Abed, Sarel, Ina, Ziv-Baran, Tomer, Schwartz, Orna, Shechtman, Yelena, Kozlener, Ella, Khoury, Rasha, Sheikh-Ahmad, Mohammad, Saiegh, Leonard, Swaid, Forat, Ahmad, Asala Abu, Janzic, Urska, Brenner, Ronen
Publicado 2023

Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe: An initiative of the Central European Cooperative Oncology Group (CECOG)

por Thallinger, Christiane, Berzinec, Peter, Bicakcic, Emina, Dan, Adelina, Fabian, Gabriella, Gales, Laurentia Nicoletta, Kuhar, Cvetka Grasic, Janzic, Urska, Kahan, Zsusanna, Mencinger, Marina, Penthedourakis, George, Sgouros, Joseph, Simetic, Luka, Sirbu, Daniela, Vosmik, Milan, Wrona, Anna, Zielinski, Christoph
Publicado 2022